Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation.
Schlegel ADepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland; Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, UK.
Muller XDepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland.
Mueller MDepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland.
Stepanova AColumbia University, Department of Pediatrics, 650 W 168th St, New York, NY 10032, U.S.A.
Kron PDepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland.
de Rougemont ODepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland.
Muiesan PLiver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, UK.
Clavien PADepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland.
Galkin AColumbia University, Department of Pediatrics, 650 W 168th St, New York, NY 10032, U.S.A.
Meierhofer DMax Planck Institute for Molecular Genetics, Mass Spectrometry Facility, Berlin, Germany.
Dutkowski PDepartment of Surgery and Transplantation, University Hospital Zurich, Switzerland. Electronic address: philipp.dutkowski@usz.ch.
English
BACKGROUND Mitochondrial succinate accumulation has been suggested as key event for ischemia reperfusion injury in mice. No specific data are however available on behavior of liver mitochondria during ex situ machine perfusion in clinical transplant models.
METHODS We investigated mitochondrial metabolism of isolated perfused rat livers before transplantation. Livers were exposed to warm and cold ischemia to simulate donation after circulatory death (DCD) and organ transport. Subsequently, livers were perfused with oxygenated Belzer-MPS for 1h, at hypothermic or normothermic conditions. Various experiments were performed with supplemented succinate and/or mitochondrial inhibitors. The perfusate, liver tissues, and isolated mitochondria were analyzed by mass-spectroscopy and fluorimetry. Additionally, rat DCD livers were transplanted after 1h hypothermic or normothermic oxygenated perfusion. In parallel, perfusate samples were analysed during HOPE-treatment of human DCD livers before transplantation.
FINDINGS Succinate exposure during rat liver perfusion triggered a dose-dependent release of mitochondrial Flavin-Mononucleotide (FMN) and NADH in perfusates under normothermic conditions. In contrast, perfusate FMN was 3-8 fold lower under hypothermic conditions, suggesting less mitochondrial injury during cold re-oxygenation compared to normothermic conditions. HOPE-treatment induced a mitochondrial reprogramming with uploading of the nucleotide pool and effective succinate metabolism. This resulted in a clear superiority after liver transplantation compared to normothermic perfusion. Finally, the degree of mitochondrial injury during HOPE of human DCD livers, quantified by perfusate FMN and NADH, was predictive for liver function.
INTERPRETATION Mitochondrial injury determines outcome of transplanted rodent and human livers. Hypothermic oxygenated perfusion improves mitochondrial function, and allows viability assessment of liver grafts before implantation.
FUNDING detailed information can be found in Acknowledgments.